Literature DB >> 16178878

Paradox of simultaneous intestinal ischaemia and hyperaemia in inflammatory bowel disease.

O A Hatoum1, D G Binion, D D Gutterman.   

Abstract

This review has focused on evidence regarding intestinal perfusion of inflammatory bowel disease (IBD). Basic investigation has defined an altered microvascular anatomy in the affected IBD bowel, which corresponds with diminished mucosal perfusion in the setting of chronic, long-standing inflammation. Diminished perfusion is linked to impaired wound healing, and may contribute to the continued refractory mucosal damage, which characterizes IBD. Alterations in vascular anatomy and physiology in IBD suggests additional possible mechanisms by which micro-vessels may contribute to the initiation and perpetuation of IBD. This begs the following questions: will angiogenesis within the gut lead to sustained inflammation, does the growing vasculature generate factors that transform the surrounding tissue and does angiogenesis generate vascular anastomosis within the gut, with shunting of blood away from the mucosal surface, impairment of metabolism and potentiation of gut damage? Further studies are required to define the mechanisms that underlie the vascular dysfunction and its role in pathophysiology of IBD.

Entities:  

Mesh:

Year:  2005        PMID: 16178878     DOI: 10.1111/j.1365-2362.2005.01567.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  22 in total

1.  An endogenously anti-inflammatory role for methylation in mucosal inflammation identified through metabolite profiling.

Authors:  Douglas J Kominsky; Simon Keely; Christopher F MacManus; Louise E Glover; Melanie Scully; Colm B Collins; Brittelle E Bowers; Eric L Campbell; Sean P Colgan
Journal:  J Immunol       Date:  2011-04-22       Impact factor: 5.422

Review 2.  Intestinal microvascular endothelium and innate immunity in inflammatory bowel disease: a second line of defense?

Authors:  Jan Heidemann; Wolfram Domschke; Torsten Kucharzik; Christian Maaser
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

3.  Bevacizumab and postponed suture leakages after surgery for ulcerative colitis and rectal cancer.

Authors:  Antoine Adenis; Luc Vanseymortier; David Foissey; Jean-Frédéric Colombel
Journal:  Gut       Date:  2007-05       Impact factor: 23.059

Review 4.  Multiple pathogenic roles of microvasculature in inflammatory bowel disease: a Jack of all trades.

Authors:  Livija Deban; Carmen Correale; Stefania Vetrano; Alberto Malesci; Silvio Danese
Journal:  Am J Pathol       Date:  2008-05-05       Impact factor: 4.307

5.  Differential signal pathway activation and 5-HT function: the role of gut enterochromaffin cells as oxygen sensors.

Authors:  Martin Haugen; Rikard Dammen; Bernhard Svejda; Bjorn I Gustafsson; Roswitha Pfragner; Irvin Modlin; Mark Kidd
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-08-30       Impact factor: 4.052

Review 6.  Targeting hypoxia in inflammatory bowel disease.

Authors:  Sean P Colgan
Journal:  J Investig Med       Date:  2016-01-11       Impact factor: 2.895

7.  Conditioned mesenchymal stem cells produce pleiotropic gut trophic factors.

Authors:  Shuhei Watanabe; Yoshiaki Arimura; Kanna Nagaishi; Hiroyuki Isshiki; Kei Onodera; Masanao Nasuno; Kentaro Yamashita; Masashi Idogawa; Yasuyoshi Naishiro; Masaki Murata; Yasushi Adachi; Mineko Fujimiya; Kohzoh Imai; Yasuhisa Shinomura
Journal:  J Gastroenterol       Date:  2013-11-12       Impact factor: 7.527

Review 8.  Hypoxia and gastrointestinal disease.

Authors:  Cormac T Taylor; Sean P Colgan
Journal:  J Mol Med (Berl)       Date:  2007-11-20       Impact factor: 4.599

Review 9.  Tissue metabolism and host-microbial interactions in the intestinal mucosa.

Authors:  Carlene Chun; Leon Zheng; Sean P Colgan
Journal:  Free Radic Biol Med       Date:  2016-09-28       Impact factor: 7.376

10.  Infiltration of mast cells in rat colon is a consequence of ischemia/reperfusion.

Authors:  Elin Sand; Anna Themner-Persson; Eva Ekblad
Journal:  Dig Dis Sci       Date:  2008-05-08       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.